Pharma: Page 2


  • Image attribution tooltip
    Jonathan Ross via Getty Images

    Pharma giants take on Appalachian cancer rates in newest screening initiative

    AstraZeneca and Bristol Myers Squibb are teaming up with the nonprofit Association of Community Cancer Centers to increase lung cancer screening in rural Appalachia for the long haul.

    By June 7, 2022
  • Image attribution tooltip

    Permission granted by David Jimenez.

    Q&A

    First 90 Days: Janssen Immunology's David Jimenez

    The long-time company man discusses the mega-drugmaker’s plans for growth and why, if you meet with him, you should plan on sipping coffee.

    By June 6, 2022
  • Image attribution tooltip
    Permission granted by Merck/Eric Rubin

    How to build a cancer pipeline: Big Pharma oncology heads on driving science forward

    Executives leading the cancer departments at J&J, Merck and Takeda chime in on what it takes to construct a successful and sustainable oncology drug pipeline.

    By June 6, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Aduhelm's Medicare woes leave questions about lofty premiums

    A single drug’s effect on the premiums that Medicare beneficiaries pay is raising questions about how these levels are set and what factors play a part.

    By Kelly Bilodeau • June 2, 2022
  • Image attribution tooltip

    Permission granted by Flagship Pioneering/Avak Kahvejian.

    Profile

    Flagship's creative approach to finding the next big idea in biopharma

    Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

    By Alexandra Pecci • June 1, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Cell and gene therapy advances coming fast and furious

    A peek into R&D at the Mass General Brigham network reveals up-and-coming treatments pushing the boundaries of what’s possible in medicine.

    By Kelly Bilodeau • June 1, 2022
  • Image attribution tooltip
    Stock via Getty Images

    SIGA prepares to kick production for monkeypox treatment into high gear

    ‘We’re not bored,’ the company’s science chief says as SIGA Technologies looks to ramp up supplies of its therapeutic.

    By May 31, 2022
  • Image attribution tooltip
    Permission granted by Sosei Heptares/Chris Cargill
    Q&A

    First 90 Days: Sosei Heptares' Chris Cargill

    The company’s new CEO is looking to drive growth through collaboration and transparency.

    By Kim Ribbink • May 31, 2022
  • Image attribution tooltip
    George Marks via Getty Images

    PBMs under fire for drug prices defend their worth

    A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they're more than just middlemen.

    By May 26, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Making moves: Inovio, Veru, MindMed and more announce key new hires

    The latest career moves in the biopharma industry from Veru, MindMed, Horizon Therapeutics and Inovio. 

    By May 25, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Ferring Pharmaceutical's Araz Raoof

    Growing up in Iraqi Kurdistan, Raoof says a 'lethal combination' of books and strong women paved her way into STEM.

    By May 25, 2022
  • Image attribution tooltip
    AndreyPopov via Getty Images

    Pharmas can be 'more than medicine' by focusing on preventative care

    Why pharma companies are changing their tack to become more than the products they sell.

    By May 24, 2022
  • Image attribution tooltip
    sturti via Getty Images
    Sponsored by ClinicalMind

    3 things medical communications can learn from sales training experts

    Medical communications is moving toward more modern approaches that can make critical information more engaging and better able to "stick".

    May 23, 2022
  • Image attribution tooltip
    Permission granted by Vidya Viswanathan

    Tracking trends in healthcare, from tech to patient care

    High-performing leaders honored by the Healthcare Businesswomen’s Association share their views on the future of the industry.

    By May 20, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Q&A

    Ironwood Pharmaceuticals is charting a course to become a giant in GI

    Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market. 

    By May 19, 2022
  • Image attribution tooltip
    John Moore via Getty Images

    A potential COVID-19 EUA could turn this small biotech into a household name

    Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

    By May 19, 2022
  • Image attribution tooltip
    Permission granted by SpringWorks/Jim Cassidy
    Profile

    Jumping into pharma with big plans at a small company

    SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.

    By Alexandra Pecci • May 17, 2022
  • Image attribution tooltip
    Spencer Platt via Getty Images
    Q&A

    BriOri BioTech sets the stage for the comeback of Vioxx

    With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.

    By Kelly Bilodeau • May 17, 2022
  • Image attribution tooltip
    Stock via Getty Images

    Are digital DCTs the answer for rare diseases?

    How data from EHRs is helping to identify, diagnose and recruit patients to decentralized clinical trials.

    By Kim Ribbink • May 16, 2022
  • Image attribution tooltip
    iStock via Getty Images

    After 40 years, researchers discover new frontiers in the fight against HIV

    Medical advances in the last two decades may now provide scientists with the right toolbox to target the long-elusive virus.

    By May 16, 2022
  • Image attribution tooltip
    Westend61 via Getty Images
    Sponsored by GoodRx

    A better approach to boosting patient engagement

    GoodRx solutions help biopharma brands overcome common barriers & increase patient engagement.

    May 16, 2022
  • Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Opinion

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    By May 12, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: AiCure's Michelle Marlborough

    As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

    By May 11, 2022
  • Image attribution tooltip
    Stock via Getty Images

    In the hot pharma talent market, execs battle these recruitment misconceptions

    One of the top recruiting firms in life sciences weighs in on how companies can attract the next wave of rising stars.

    By May 11, 2022
  • Image attribution tooltip
    iStock via Getty Images

    It's time to acknowledge access as a prescribing barrier

    A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

    By May 11, 2022